ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CLRB Company Profile and Key Details

NASDAQ : CLRB

Cellectar Biosciences, Inc.

$0.28

0.0023+0.84%

Open: 12:10 PM

63.16

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CLRB Stock Price Chart

Stock Price Today

Cellectar Biosciences, Inc. (CLRB) stock surged +0.84%, trading at $0.28 on NASDAQ, up from the previous close of $0.27. The stock opened at $0.28, fluctuating between $0.27 and $0.28 in the recent session.

Stock Snapshot

0.2728

Prev. Close

0.28

Open

12.68M

Market Cap

46.08M

Number of Shares

0.2672

Day Low

0.28

Day High

-0.2

P/E Ratio

98.33%

Free Float in %

-1.4

EPS (TTM)

-0.07

Book Value

-1.79

Cash Flow per Share

113.77K

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 10, 2025	0.27	0.29	0.25	0.27	642.9K
Apr 09, 2025	0.24	0.28	0.23	0.25	830.89K
Apr 08, 2025	0.25	0.26	0.23	0.24	681.19K
Apr 07, 2025	0.26	0.28	0.25	0.25	1.27M
Apr 04, 2025	0.29	0.29	0.23	0.26	1.65M
Apr 03, 2025	0.30	0.31	0.29	0.29	603.32K
Apr 02, 2025	0.29	0.31	0.29	0.30	809.27K
Apr 01, 2025	0.32	0.33	0.29	0.29	612.45K
Mar 31, 2025	0.32	0.34	0.31	0.32	796.1K
Mar 28, 2025	0.36	0.37	0.33	0.33	741.86K
Mar 27, 2025	0.37	0.38	0.36	0.36	251.5K
Mar 26, 2025	0.38	0.38	0.36	0.36	379.75K
Mar 25, 2025	0.38	0.39	0.37	0.39	516.4K
Mar 24, 2025	0.36	0.40	0.36	0.39	517.3K
Mar 21, 2025	0.38	0.39	0.34	0.37	1.31M
Mar 20, 2025	0.38	0.41	0.37	0.38	872.32K
Mar 19, 2025	0.39	0.40	0.37	0.39	1.55M
Mar 18, 2025	0.34	0.39	0.34	0.38	2.55M
Mar 17, 2025	0.31	0.34	0.31	0.34	1.62M
Mar 14, 2025	0.30	0.32	0.27	0.32	1.35M

Contact Details

Florham Park, NJ 07932

United States

Website: https://www.cellectar.comContact: 608 441 8120

About Company

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.

Frequently Asked Questions

What is the current Cellectar Biosciences, Inc. (CLRB) stock price?

Cellectar Biosciences, Inc. (NASDAQ: CLRB) stock price is $0.28 in the last trading session. During the trading session, CLRB stock reached the peak price of $0.28 while $0.27 was the lowest point it dropped to. The percentage change in CLRB stock occurred in the recent session was 0.84% while the dollar amount for the price change in CLRB stock was $0.00.

CLRB's industry and sector of operation?

The NASDAQ listed CLRB is part of Biotechnology industry that operates in the broader Healthcare sector. Cellectar Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CLRB?

Mr. Jarrod Longcor
Chief Operating Officer
Mr. Darrell Shane Lea
Chief Commercial Officer
Mr. Shane Lea
Chief Commercial Officer
Mr. Andrei Shustov M.D.
Senior Vice President of Medical
Mr. James V. Caruso
Pres, Chief Executive Officer & Director
Mr. Chad J. Kolean C.P.A., CPA
Vice President, Chief Financial Officer & Sec.
Dr. Andrei Shustov M.D.
Senior Vice President of Medical
Mr. Chad J. Kolean CPA, CPA
Vice President, Chief Financial Officer & Sec.

How CLRB did perform over past 52-week?

CLRB's closing price is 24% higher than its 52-week low of $0.22 where as its distance from 52-week high of $3.73 is -92.69%.

How many employees does CLRB have?

Number of CLRB employees currently stands at 11.

Link for CLRB official website?

Official Website of CLRB is: https://www.cellectar.com

How do I contact CLRB?

CLRB could be contacted at phone 608 441 8120 and can also be accessed through its website. CLRB operates from 100 Campus Drive, Florham Park, NJ 07932, United States.

How many shares of CLRB are traded daily?

CLRB stock volume for the day was 113.77K shares. The average number of CLRB shares traded daily for last 3 months was 1.63M.

What is the market cap of CLRB currently?

The market value of CLRB currently stands at $12.68M with its latest stock price at $0.28 and 46.08M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	11
Beta	0.96
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology